Associated Papers
Common gene mutations in 103 authenticated colorectal cancer cell lines.
Kranjec C et al.
Oncogenesis, 2026
41593049 (PubMed )
Supplement: 41389_2026_599_MOESM2_ESM.xlsx › Supplementary_Table_9
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors.
Menzel M et al.
The Journal of Pathology. Clinical Research, 2024
38284983 (PubMed )
Supplement: CJP2-10-e354-s001.zip › cjp2354-sup-TableS2.xlsx › Table_S2
Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer.
Lee K et al.
Scientific Reports, 2023
37336919 (PubMed )
Supplement: 41598_2023_35925_MOESM1_ESM.xlsx › Table_S4__patho_variants_
The High Expression of p53 Is Predictive of Poor Survival Rather TP53 Mutation in Esophageal Squamous Cell Carcinoma.
Jin Y et al.
Journal of Oncology, 2023
Identification of relevant genetic alterations in cancer using topological data analysis.
Rabadán R et al.
Nature Communications, 2020
32732999 (PubMed )
Supplement: 41467_2020_17659_MOESM3_ESM.xls › TableS1
The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies.
Martin D et al.
Oncotarget, 2014
25275298 (PubMed )
Supplement: oncotarget-05-8906-s001.pdf
Epigenetic and genetic features of 24 colon cancer cell lines.
Ahmed D et al.
Oncogenesis, 2013
Select a paper to view details